Tag: CBT > DEA Rescheduling: Page 7

Banking Services Cannabis Industry

Federal Marijuana Rescheduling on the Horizon: A Big Step Forward But Not the Be-All-End-All

Rescheduling does not make cannabis legal throughout America and the U.S. territories; It makes cannabis a federally regulated medication—and many questions remain about the fate of the industry.

May 23, 2024

Cannabis Rescheduling

Cannabis Industry Reacts to Biden’s Rescheduling Announcement

The President’s May 16 announcement is being touted as an important and historic first step, but many industry constituents say there’s still a long way to go, with social justice at the heart of pushes for decriminalization. Here are reactions from cannabis business executives, industry organizations, lawyers and members of Congress.

May 17, 2024

Cannabis Rescheduling

White House Moves to Reschedule Cannabis in ‘Monumental’ Decision, Biden Says

The Department of Justice will issue a notice of proposed rulemaking to reclassify cannabis in the Federal Register, which will be followed by a 60-day public comment period prior to the department potentially finalizing the rule.

May 16, 2024

Federal Cannabis Legalization

Cannabis Rescheduling: Where Do We Go From Here?

The legal team at Vicente addressed the significance of the potential move to reschedule cannabis, detailing the ramifications for state-legal cannabis businesses and what could happen next, during a webinar. Here are 12 key takeaways from the event.

May 10, 2024

Cannabis Rescheduling

Cannabis Rescheduling FAQ: What Now?

From potential timelines to 280E to SAFER Banking, legal experts explain the implications of the federal government reclassifying cannabis as a less dangerous substance.

May 6, 2024

Cannabis Rescheduling

Former Deputy Attorney General James Cole Weighs in on Cannabis Rescheduling and What’s Next

Cole spoke on a media call organized by industry groups and said Congress must ‘act to create a unified regulatory environment that involves both the states and the federal government.’

May 1, 2024

Cannabis Rescheduling

Cannabis Rescheduling Reactions Mixed: While Some Applaud Potential, Others Push For More

Executives, lawmakers and nonprofit leaders weigh in on the significance and shortcomings of the DEA's move to reclassify cannabis as a less dangerous substance.

May 1, 2024

Cannabis Rescheduling

UPDATE: DEA Moves to Reschedule Cannabis

The federal agency that has long enforced prohibition aligns with the recommendation from the U.S. Department of Health and Human Services, FDA to reclassify cannabis as a Schedule III substance under the Controlled Substances Act.

April 30, 2024

Cannabis Rescheduling

Cannabis Rescheduling Update: Is a ‘Notoriously Secretive Agency’ Now Involved?

A report that HHS requested an opinion from the Department of Justices’ Office of Legal Counsel raises new questions and concerns. Attorney Shane Pennington explains why that request and the outcome would be crucial to the schedule review process and the industry’s future.

April 29, 2024

Cannabis Rescheduling

21 US Lawmakers Express Frustration With DEA’s Inaction on Cannabis Rescheduling

The 11 senators and 10 House representatives urged for swift action to remove cannabis from a Schedule I listing in a new letter.

April 25, 2024

California

The State of Federal Cannabis Reform Leads CBT’s Most-Read Articles in April

4/20 deals and events, California tax defaults, and nationwide municipal opt outs also highlighted Cannabis Business Times’ most popular stories this month.

April 25, 2024

Legislation and Regulation

Federal Cannabis Legalization and Reform: Where Are We in 2024?

U.S. cannabis reform hasn’t come easy amid a divided Congress, but plenty of opportunities remain on the table for the remainder of the year.

April 20, 2024